what are the risks of glp-1 drugs Medications: Is Ozempic Best Option for You? GLP-1 Medications: Everything You Need

In a randomized, placebo-controlled trial of semaglutide treatment, 62 % of adolescent participants in the semaglutide group achieved a loss of body weight of at least 10 %, with 37 % of subjects achieving weight reduction of at least 20 % [138,156]

References Min T, Bain SC

Liraglutide and weight loss among patients with advanced heart failure and a reduced ejection fraction: insights from the FIGHT trial

1% Ozempic 0.7% liraglutide 0.3% Contrave Further, the research suggests that injectable semaglutide and liraglutide drugs are four times more likely to cause bowel obstruction and nine time more likely to cause pancreatitis when compared to Contrave

Previous studies have found that ceasing use of GLP-1 agonists results in patients regaining some or all of the weight they'd lost while taking the medication